Matt Zorn

Matt Zorn is an intellectual property, commercial, and regulatory litigator that for the past 3 years has been at the bleeding edge of drug policy litigation against the government. He is a partner at Yetter Coleman LLP and represents an array of clients in different industries. Matt also writes essays on drug regulation on the On Drugs newsletter at

4 Articles Published | Follow: